Loading company…
Riskpilot
← Back to search
Sign in
Get full access
VaccImmune ApS
APS
In liquidation
CVR 39434520
Gammel Strandvej 18
Ikke-finansielle holdingselskaber · NACE 642020
Est. 2018
— employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2020
DKK 22K
EBITDA margin
100.0%
+354% vs 2019
Equity ratio
0.0%
Financial strength
Net profit 2020
DKK 22K
+290% vs 2019
EBITDA — year on year
DKK millions
0M
0M
1M
1M
1M
0M
2018
0M
0%
2019
0M
0%
2020
Key figures
Annual report 2020
Revenue
DKK 22K
—
EBITDA
DKK 22K
+354%
Net profit
DKK 22K
+290%
Total assets
DKK 19K
-90%
Equity
DKK 1
+100%
Employees
—
—
Company information
Legal name
VaccImmune ApS
CVR number
39434520
Legal form
Anpartsselskab
NACE code
642020 · Ikke-finansielle holdingselskaber
Founded
12. marts 2018
Share capital
DKK 40.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2020-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Contact
Address
Gammel Strandvej 18
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Ikke-finansielle holdingselskaber
Companies in Fredensborg
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2018
0M
2019
0M
2020
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2018
0M
2019
0M
2020
Income statement
DKK thousands
Item
2018
2019
2020
Revenue
—
—
22
Staff expenses
-0
-0
-0
EBITDA
-13
-9
22
Depreciation & amort.
-0
-0
-0
EBIT
-13
-9
22
Net financials
0
0
0
Profit before tax
-13
-9
22
Tax
-3
3
-0
Net profit
-10
-12
22
Balance sheet
DKK thousands
Item
2018
2019
2020
Total assets
188
185
19
Equity
-10
-22
0
Long-term debt
0
0
0
Short-term debt
198
207
19
Total debt
198
207
19
Financial ratios
5-year trend
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
2018
2020
Equity ratio
0.0%
This company
38.2%
Market median
-100% vs market
2018
2020
Return on equity
2218800.0%
This company
18.4%
Market median
+12058596% vs market
2018
2020
Net profit margin
100.0%
This company
8.1%
Market median
+1135% vs market
2018
2020
Asset turnover
1.16×
This company
1.12×
Market median
+4% vs market
2018
2020
Debt / equity
19099.00×
This company
0.62×
Market median
-3080384% vs market
2018
2020
Annual reports & filings
Annual report 2020
Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
View
PDF
Annual report 2018
Filed via CVR / Virk · Period 2018-03-12 – 2018-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
MA
Morten Albrechtsen
Chief Executive Officer
Chief Executive Officer
2018
—
—
AR
Anders Rubinstein
Unofficial title
Unofficial title
2020
—
—
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
WEXOTEC ApS
Company
50.0%
50.0%
2018
Nobiex IVS
Company
33.3%
33.3%
2018
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of VaccImmune ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Morten Albrechtsen
Chief Executive Officer
0 companies
Anders Rubinstein
Unofficial title
0 companies